NDT Pharmaceuticals Inc. (NDTP)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Total Assets | 142.97 Thousand | - | - | - | - | 50 Thousand |
| Total Current Assets | 647.00 | - | - | - | - | - |
| Cash And Short Term Investments | 647.00 | - | - | - | - | - |
| Cash and Cash Equivalents | 647.00 | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | 142.32 Thousand | - | - | - | - | 50 Thousand |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | 50 Thousand |
| Good Will | - | - | - | - | - | 50 Thousand |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | 142.32 Thousand | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | -1.00 | - | - | - | - | - |
| Other Assets | 1.00 | - | - | - | - | - |
| Total Liabilities | 41.79 Thousand | - | - | - | - | 358.97 Thousand |
| Total Current Liabilities | 41.79 Thousand | - | - | - | - | 358.97 Thousand |
| Account Payables | - | - | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | - | 350 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 41.79 Thousand | - | - | - | - | 8971.00 |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 101.17 Thousand | - | - | - | - | -308.97 Thousand |
| Stock Holders Equity | 101.17 Thousand | - | - | - | - | -308.97 Thousand |
| Common Stock | 16 Thousand | - | - | - | - | 302.00 |
| Retained Earnings | -106.79 Thousand | - | - | - | - | -309.32 Thousand |
| Accumulated other comprehensive income | - | - | - | - | - | -302.00 |
| Common Stock Equity | 101.17 Thousand | - | - | - | - | -308.97 Thousand |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | 142.32 Thousand | - | - | - | - | - |
| Total Debt | - | - | - | - | - | 350 Thousand |
| Net Debt | -647.00 | - | - | - | - | 350 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 142.97 Thousand | 142.97 Thousand | 142.97 Thousand | 142.97 Thousand | 142.97 Thousand | 142.97 Thousand |
| Total Current Assets | 647.00 | 647.00 | 647.00 | 647.00 | 647.00 | 647.00 |
| Cash And Short Term Investments | 647.00 | 647.00 | 647.00 | 647.00 | 647.00 | 647.00 |
| Cash and Cash Equivalents | 647.00 | 647.00 | 647.00 | 647.00 | 647.00 | 647.00 |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 |
| Other Assets | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Liabilities | 53.48 Thousand | 43.31 Thousand | 41.79 Thousand | 41.79 Thousand | 39.07 Thousand | 37.02 Thousand |
| Total Current Liabilities | 53.48 Thousand | 43.31 Thousand | 41.79 Thousand | 41.79 Thousand | 39.07 Thousand | 37.02 Thousand |
| Account Payables | - | - | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | - | - |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 53.48 Thousand | 43.31 Thousand | 41.79 Thousand | 41.79 Thousand | 39.07 Thousand | 37.02 Thousand |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | -53.48 Thousand | - | - | - | - | - |
| Total Equity | 89.48 Thousand | 99.65 Thousand | 101.17 Thousand | 101.17 Thousand | 103.89 Thousand | 105.95 Thousand |
| Stock Holders Equity | 89.48 Thousand | 99.65 Thousand | 101.17 Thousand | 101.17 Thousand | 103.89 Thousand | 105.95 Thousand |
| Common Stock | 16 Thousand | 16 Thousand | 16 Thousand | 16 Thousand | 16 Thousand | 16 Thousand |
| Retained Earnings | -118.47 Thousand | -108.31 Thousand | -106.79 Thousand | -106.79 Thousand | -104.07 Thousand | -102.01 Thousand |
| Accumulated other comprehensive income | - | - | - | - | - | - |
| Common Stock Equity | 89.48 Thousand | 99.65 Thousand | 101.17 Thousand | 101.17 Thousand | 103.89 Thousand | 105.95 Thousand |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand | 142.32 Thousand |
| Total Debt | - | - | - | - | - | - |
| Net Debt | -647.00 | -647.00 | -647.00 | -647.00 | -647.00 | -647.00 |
9556
AZN
229000
PURI
9514
DUELL